Malaria is an infectious disease caused by a parasite known as Plasmodium, and is transmitted by some female Anopheles mosquitoes. According to the World Health Organization (WHO), 198 million cases of malaria were identified in 2013 together with 584,000 deaths. Malaria mainly affects children under five years of age and pregnant women. 80% of cases are recorded in sub-Saharan Africa.
After the infection has been contracted, the most classic symptom is the cyclical repetition of sudden coldness followed by shivering, fever, and sweating for four to six hours, occurring regularly at longer or shorter intervals depending on the type of infection. Severe malaria, which is caused exclusively by the parasite Plasmodium falciparum, may result in coma and death if not treated.
The last decade has seen an expansion in the funding and coverage of malaria control programs. This has resulted in a large-scale reduction in malaria incidence and mortality. As of yet, however, there is no commercially available vaccine.
AMP supports activities to improve the prevention and control of malaria in collaboration with partners from the private and public sector.